Skip to main content

UBS Group AG

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1610520 ZURICH, V8

Position in RIGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,809,960
+$3,455,905 QoQ
Shares Held
122,954
+145.5% QoQ
Ownership
0.658%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 156 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,364,122 across 562 Biotechnology names. RIGL ranks #149 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,809,960 122,954
2026-03-31 $1,354,055 50,076
2025-12-31 $1,988,938 46,438
2025-09-30 $2,849,911 100,597
2025-06-30 $1,274,687 68,056
2025-03-31 $840,402 46,715
2024-12-31 $229,878 13,667
2024-09-30 $148,467 9,176
2024-03-31 $265,162 179,164
2023-12-31 $219,476 151,363
2023-09-30 $84,425 78,172
2023-06-30 $147,334 114,213
2023-03-31 $95,106 72,051
2022-12-31 $34,555 23,037
2022-06-30 $667,669 590,858
2022-03-31 $888,194 297,055
2021-12-31 $1,115,609 420,985
2021-09-30 $57,470 15,832
2021-06-30 $190,173 43,819
2021-03-31 $1,076,441 314,749
2020-06-30 $63,790 34,858
2020-03-31 $123,561 79,206